SNX14
protein-codingsorting nexin 14, the group of Sorting nexins
Gene summary
This gene encodes a member of the sorting nexin family. Members of this family have a phox (PX) phosphoinositide binding domain and are involved in intracellular trafficking. The encoded protein also contains a regulator of G protein signaling (RGS) domain. Regulator of G protein signaling family members are regulatory molecules that act as GTPase activating proteins for G alpha subunits of heterotrimeric G proteins. Alternate splicing results in transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~89.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014601
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0014601
Submitter: ClinGen
Sorting nexin 14 (*SNX14*) was first reported in relation to autosomal recessive spinocerebellar ataxia 20 (SCAR20) in 2014 (Thomas et al., PMID: 25439728). SCAR20 is a pediatric onset disease which often involves ataxia, cerebellar atrophy, coarse facial features and intellectual disability (PMIDs 25439728, 25848753). Six variants (two stop-gain, one frame shift, one missense, one canonical splice, and one deep intronic) that have been reported in six probands in four publications (PMIDs: 25439728, 25848753, 27913285, 37485342) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence has been reached. The mechanism of pathogenicity is known to be loss of function. This gene-disease relationship is also supported by animal models, cell culture models, and biochemical data (PMIDs 33310904, 38625743, 29635513). The effects from a loss of function or expression was shown to be more pronounced in cerebral tissue and that disruption to lipid homeostasis is likely involved in pathogenesis. In summary, there is definitive evidence supporting the relationship between *SNX14* and autosomal recessive spinocerebellar ataxia 20. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Cerebellar Ataxia GCEP on the meeting date October 9, 2024 (SOP Version 11).
Inheritance Pattern: AR
Disease ID:MONDO:0014601
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014601
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014601
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0014601
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SNX14 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_153816.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 46 | 2 | 51 | ||
| missense | 1 | 158 | 5 | 1 | 165 | |
| nonsense | 4 | 12 | 16 | |||
| start loss | 0 | |||||
| frameshift | 8 | 9 | 17 | |||
| splice donor/acceptor (+/-2bp) | 4 | 13 | 12 | 29 | ||
| Total | 17 | 34 | 173 | 51 | 3 | 278 |
Highest pathogenic variant AF is 0.000047786907
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_722523.1 | 29 | MANE Select | |
| Ensembl | ENSP00000313121.3 | 29 | MANE Select | |
| RefSeq | NP_001284543.1 | 28 | Standard | |
| RefSeq | NP_001291408.1 | 28 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| snx14 | Danio rerio | Structure: neuron Quality: apoptotic abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Biological Process
- protein transport
- autophagosome maturation
Molecular Function
- phosphatidylinositol-3,5-bisphosphate binding
Cellular Component
- lysosome
- lysosomal membrane
- late endosome
- integral component of membrane
- dendrite
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000314673
- Coding exons
- 29
- Length
- 88661
- Individuals with no LoFs
- 125650
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 98
- Defined
- 125748
- p
- 0.000390
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.85 | 350 | 462 | 0.758 | 0.0000218 | 6215 |
| Missense (PolyPhen) | 87 | 141.32 | 0.61564 | 1963 | ||
| Synonymous | -0.719 | 169 | 158 | 1.07 | 0.00000731 | 1692 |
| Loss of Function | 2.61 | 35 | 56.1 | 0.624 | 0.00000270 | 748 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00038 | 0.00037 | rare |
| Latino/Admixed American | 0.00015 | 0.00014 | rare |
| Ashkenazi Jewish | 0.000099 | 0.000099 | rare |
| East Asian | 0.0012 | 0.0011 | notable |
| Finnish | 0.00014 | 0.00014 | rare |
| European (Non-Finnish) | 0.00044 | 0.00042 | rare |
| South Asian | 0.00040 | 0.00039 | rare |
| Other | 0.00034 | 0.00033 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Plays a role in maintaining normal neuronal excitability and synaptic transmission. May be involved in several stages of intracellular trafficking (By similarity). Required for autophagosome clearance, possibly by mediating the fusion of lysosomes with autophagosomes (Probable). Binds phosphatidylinositol 3,5-bisphosphate (PtdIns(3,5)P2), a key component of late endosomes/lysosomes (PubMed:25848753). Does not bind phosphatidylinositol 3-phosphate (PtdIns(3P)) (PubMed:25848753, PubMed:25148684). {ECO:0000250|UniProtKB:Q8BHY8, ECO:0000269|PubMed:25148684, ECO:0000269|PubMed:25848753, ECO:0000305|PubMed:25848753}.;
Recessive Scores
- pRec
- 0.108
Intolerance Scores
- LoFtool
- 0.964
- RVIS EVS
- -0.49
- RVIS percentile EVS
- 22.65
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.508
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |